Actively Recruiting
Randomized Phase 3 Trial of Aspirin Combined With Cilostazol or Clopidogrel for Treating Minor Ischemic Stroke or Transient Ischemic Attack
Led by Kafrelsheikh University · Updated on 2024-09-19
870
Participants Needed
1
Research Sites
2 weeks
Total Duration
AI-Summary
What this Trial Is About
Researchers are evaluating the efficacy and safety of combining aspirin with either clopidogrel or cilostazol in adults who have experienced a minor ischemic stroke or transient ischemic attack TIA. This randomized controlled trial aims to compare a 300 mg loading dose of clopidogrel given within 24 hours of the first minor stroke or TIA to a 200 mg loading dose of cilostazol, measuring outcomes such as new stroke rates and adverse effects over 90 days. The study was approved by the ethics committee of Kafr el-Sheik University and involves patients aged 18 to 75 years who received antiplatelet treatment shortly after stroke onset.
CONDITIONS
Brief Title
Combining Aspirin With Cilostazol or Clopidogrel in Minor Stroke or TIA
Research Team
M
mohamed G. Zeinhom, MD
S
sherihan R. ahmed, MD
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
